Open access

Burden of Mesothelioma in China, 1990–2023: Trends, Decomposition, and Projections Until 2045

Kang Hu Qichen Ye Rong-Rong Zhao Chao Ma Xiao Zhang Tian-Hao Xie Chen-ye Shao Cheng Ding Jun Zhao Hao Ding

Aug 2026 · Cancers · Vol 18, pp. 2521 · 1 citation · 34 references

Medicine

TL;DR

From 1990 to 2023, China’s mesothelioma burden rose sharply, with cases up 189% and deaths up 142%, mainly affecting older males, mainly affecting older males.

Abstract

Simple Summary From 1990 to 2023, China’s mesothelioma burden rose sharply, with cases up 189% and deaths up 142%, mainly affecting older males. While age-standardized death and disability rates stabilized or fell, population growth and aging drove the overall increase, and deaths are projected to keep rising through 2045. The study calls for better asbestos surveillance, diagnostics, and cancer care to reduce future impact.

DOI PubMed Semantic Scholar

Read PDF

Similar papers

Open access Sep 2026

A Comparative Analysis of Multiple Myeloma Disease Burden in China and Globally From 1990 to 2023 and Future Trend Projections

Trends in the age‐ and sex‐specific burden of MM in China from 1990 to 2023, including incidence, prevalence, mortality, and disability‐adjusted life years (DALYs); projects sex‐specific incidence to 2050; and compares findings globally.

Fu Zhu, Hui-Ting Wang · Cancer Medicine · 0 citations

Sep 2026

Burden of cancer in China from 1990 to 2023 and projections to 2050.

Dan Wang, Zhen-Zhen Rao, Wei Xiong et al. · Science China Life Sciences · 0 citations

Sep 2026

Comprehensive analysis of colorectal cancer burden in G20 countries from 1990 to 2023 and projections to 2030: findings from the Global Burden of Disease Study 2023.

Despite substantial declines in age-standardized mortality and DALY rates, absolute CRC burden in G20 countries has increased dramatically over three decades, driven by population growth and aging.

Ke Zhang, Zhi-Fei Chen · Digestive Diseases · 0 citations

Open access Sep 2026

The Burden of Pancreatic Cancer in ASEAN Member States (1990-2023) and Future Trends Forecasting: A GBD 2023 Analysis.

OBJECTIVE To characterize temporal trends, demographic drivers, and socioeconomic inequalities in pancreatic cancer burden across the 11 Association of Southeast Asian Nations (ASEAN) member states and to project burden through 2050. PATIENTS AND METHODS We analyzed Global Burden of Disease 2023 estimates for 11 ASEA...

Kang Fu, Yang-Dong Wu, Zhen-Yuan Liu et al. · Mayo Clinic proceedings · 0 citations

Open access Aug 2026

The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023

This study aimed to assess the burden of MBC in Central, Eastern, and Western Europe from 1990 to 2023, using data from the Global Burden of Disease (GBD) Study 2023.

Roberto Passera, E. Fabbro, Giulia Zamagni · Cancer · 0 citations

Open access Sep 2026

Burdens of Malignant Melanoma and Projections for 2050 in Asia: Findings from the 2023 Global Burden of Disease Study

Asia faces a dual challenge: rising incidence and a progressive eastward/southward burden shift to lower‑SDI countries; effective responses require equitable, context-specific strategies combining sun‑safety campaigns, early detection, advanced diagnostics, and affordable treatments across socioeconomic strata.

Chao-Chao Lu, Chen-Chang He, Guo-Fang Wang et al. · Clinical, Cosmetic and Inves... · 0 citations